Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bristol-Myers Squibb Company - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BMY
New York
2830
www.bms.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bristol-Myers Squibb Company
Why Is Pfizer Stock Paying You So Much To Wait?
- Sep 14th, 2026 1:57 pm
3 Healthcare Stocks That Fall Short
- Sep 14th, 2026 9:23 am
Bispecifics Market to Gain Momentum During the Forecast Period (2026-2036) with Expanding Pipeline and Increasing Therapeutic Adoption | DelveInsight
- Sep 14th, 2026 8:31 am
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
- Sep 14th, 2026 7:05 am
Big Pharma Is Pouring Billions Into China’s Biotechs
- Sep 14th, 2026 1:59 am
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
- Sep 13th, 2026 1:53 pm
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
- Sep 12th, 2026 1:15 pm
Is AbbVie Stock Actually Overpriced?
- Sep 11th, 2026 1:11 pm
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
- Sep 11th, 2026 9:17 am
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
- Sep 11th, 2026 9:16 am
Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors
- Sep 10th, 2026 3:45 pm
Revolution Medicines Got a ‘Miracle’ Cancer Drug Approval. Wall Street Wants More.
- Sep 10th, 2026 12:40 pm
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?
- Sep 10th, 2026 11:47 am
Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says
- Sep 10th, 2026 10:08 am
Why Has AbbVie Gone Quiet About Humira?
- Sep 10th, 2026 9:05 am
Amgen's Forward Multiple Looks Cheap Until You Price The Margins It Assumes
- Sep 9th, 2026 8:32 pm
Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?
- Sep 9th, 2026 3:34 pm
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?
- Sep 9th, 2026 9:14 am
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
- Sep 9th, 2026 6:00 am
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort
- Sep 9th, 2026 5:29 am
Scroll